View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 13, 2017updated 19 Oct 2017 12:05pm

Cyatt and CardioComm sign JV agreement for patient monitoring technology

US-based health technology solutions provider Cytta has signed a joint venture (JV) agreement with Canadian cardiovascular devices firm CardioComm Solutions for a remote patient monitoring platform, VeriSmartPhone.

By Daniel Garrun

US-based health technology solutions provider Cytta has signed a joint venture (JV) agreement with Canadian cardiovascular devices firm CardioComm Solutions for a remote patient monitoring platform, VeriSmartPhone.

As per the agreement, CardioComm’s HeartCheck and GEMS ECG technologies will be integrated with Cytta’s EvrCare Health and Wellness Platform to implement the web-based VeriSmartPhone.

The EvrCare solution builds on Cytta’s new Superior Utilisation of Processing for Error Resilience (SUPER) video and data compression/decompression solution designed to minimise data file size, improve data transfer speed, and decrease telemedicine communication costs.

CardioComm’s ECG solutions software accepts raw data from any device through Bluetooth and generates an accurate ECG trace with information on recording, review and report.

The EvrCare telemedicine platform with CardioComm ECG analysis tools will be used to manage all reports, findings and related patient information to deliver the ECG findings and other EvrCare related peripherals used for monitoring.

“CardioComm’s ECG solutions software accepts raw data from any device through Bluetooth and generates an accurate ECG trace with information on recording, review and report.”
Intended for single and group users, the integrated solution is expected to allow real-time tracking, evaluation and management of biometric information from all connected health and wellness devices.

Cytta also intends to add a doctor-directed platform that will enable caregivers and insurers to prescribe devices to improve long-term care for people who are at high risk of disease onset or have chronic medical conditions.

Planned to be initially launched in the US, the EvrCare VeriSmartPhone platform is intended to eliminate technological, workflow and infrastructure challenges associated with remote patient monitoring solutions for mobile cardiac telemetry, arrhythmia and prolonged QT interval screening.

The technology is also expected to be useful for in-hospital and in-clinic services, as well as pre/post-hospital surgery discharge monitoring.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU